Show simple item record

dc.contributor.authorKugel, Daniela
dc.contributor.authorPulverer, Julia Elisabeth
dc.contributor.authorKöster, Mario
dc.contributor.authorHauser, Hansjörg
dc.contributor.authorStaeheli, Peter
dc.date.accessioned2011-09-23T12:09:53Z
dc.date.available2011-09-23T12:09:53Z
dc.date.issued2011-04
dc.identifier.citationNovel nonviral bioassays for mouse type I and type III interferon. 2011, 31 (4):345-9 J. Interferon Cytokine Res.en
dc.identifier.issn1557-7465
dc.identifier.pmid21138377
dc.identifier.doi10.1089/jir.2010.0079
dc.identifier.urihttp://hdl.handle.net/10033/142969
dc.description.abstractWe used embryo fibroblasts from Mx2-Luc transgenic mice that express Firefly luciferase under control of the interferon (IFN)-regulated mouse Mx2 promoter to develop simple nonviral bioassays for type I and type III IFN. Since type III IFN is acid-labile, Mx2-Luc fibroblasts detected the presence of type I IFN in acid-treated biological samples with high sensitivity and selectivity. For selective detection of type III IFN, we employed embryo fibroblasts from Mx2-Luc mutant mice that lack functional receptors for type I IFN. The sensitivity of this latter assay remained comparatively low, presumably because type III IFN receptors are not abundantly present on fibroblasts. The main advantages of our novel IFN assays are that they are easy to perform, yield fast results, and can be used in laboratories that are not licensed for work with infectious agents. Further, the type I IFN assay has superior sensitivity than commercially available enzyme-linked immunosorbent assay systems.
dc.language.isoenen
dc.titleNovel nonviral bioassays for mouse type I and type III interferon.en
dc.typeArticleen
dc.contributor.departmentDepartment of Virology, University of Freiburg, Freiburg, Germany.en
dc.identifier.journalJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Researchen
refterms.dateFOA2018-06-12T22:19:11Z
html.description.abstractWe used embryo fibroblasts from Mx2-Luc transgenic mice that express Firefly luciferase under control of the interferon (IFN)-regulated mouse Mx2 promoter to develop simple nonviral bioassays for type I and type III IFN. Since type III IFN is acid-labile, Mx2-Luc fibroblasts detected the presence of type I IFN in acid-treated biological samples with high sensitivity and selectivity. For selective detection of type III IFN, we employed embryo fibroblasts from Mx2-Luc mutant mice that lack functional receptors for type I IFN. The sensitivity of this latter assay remained comparatively low, presumably because type III IFN receptors are not abundantly present on fibroblasts. The main advantages of our novel IFN assays are that they are easy to perform, yield fast results, and can be used in laboratories that are not licensed for work with infectious agents. Further, the type I IFN assay has superior sensitivity than commercially available enzyme-linked immunosorbent assay systems.


Files in this item

Thumbnail
Name:
Kugel et al_final.pdf
Size:
372.6Kb
Format:
PDF
Description:
allowed publisher's PDF

This item appears in the following Collection(s)

Show simple item record